Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study

S. Junius,Karin Haustermans,Barbara Bussels,Raymond Oyen,Bianca Vanstraelen,Tom Depuydt,Jan Verstraete,Steven Joniau,Hendrik Van Poppel

Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study

2007

S. Junius
Karin Haustermans
Barbara Bussels
Raymond Oyen
Bianca Vanstraelen
Tom Depuydt
Jan Verstraete
Steven Joniau
Hendrik Van Poppel

Background To assess acute (primary endpoint) and late toxicity, quality of life (QOL), biochemical or clinical failure (secondary endpoints) of a hypofractionated IMRT schedule for prostate cancer (PC).

Keywords:

Radiology
Medical physics
Clinical endpoint
Acute toxicity
Prostate cancer
Radiation therapy
Medicine
clinical failure
late toxicity
phase i ii
Irradiation
Quality of life

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations